Cailian Liu

10.7k total citations · 1 hit paper
34 papers, 2.1k citations indexed

About

Cailian Liu is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Cailian Liu has authored 34 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 23 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Cailian Liu's work include Immunotherapy and Immune Responses (18 papers), Cancer Immunotherapy and Biomarkers (15 papers) and CAR-T cell therapy research (14 papers). Cailian Liu is often cited by papers focused on Immunotherapy and Immune Responses (18 papers), Cancer Immunotherapy and Biomarkers (15 papers) and CAR-T cell therapy research (14 papers). Cailian Liu collaborates with scholars based in United States, Japan and Australia. Cailian Liu's co-authors include Jedd D. Wolchok, Taha Merghoub, Sadna Budhu, Alan N. Houghton, Hong Zhong, Miguel‐Angel Perales, Adam D. Cohen, Gabrielle Rizzuto, Yanyun Li and Roberta Zappasodi and has published in prestigious journals such as Nature Medicine, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Cailian Liu

32 papers receiving 2.1k citations

Hit Papers

Blockade of the AHR restricts a Treg-macrophage suppressi... 2020 2026 2022 2024 2020 100 200 300

Peers

Cailian Liu
Shui Cao China
Helena Harlin United States
Xuguang Tai United States
Eva Ellebæk Denmark
Zoe Briggs United Kingdom
Montaser Shaheen United States
Glenn R. Bantug Switzerland
Sung Hoon Cho United States
Meixiao Long United States
Mengkun Zhang United States
Shui Cao China
Cailian Liu
Citations per year, relative to Cailian Liu Cailian Liu (= 1×) peers Shui Cao

Countries citing papers authored by Cailian Liu

Since Specialization
Citations

This map shows the geographic impact of Cailian Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cailian Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cailian Liu more than expected).

Fields of papers citing papers by Cailian Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cailian Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cailian Liu. The network helps show where Cailian Liu may publish in the future.

Co-authorship network of co-authors of Cailian Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Cailian Liu. A scholar is included among the top collaborators of Cailian Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cailian Liu. Cailian Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Min, Lei Feng, Cailian Liu, et al.. (2025). Knowledge, attitudes, and practices regarding whole-course management among patients with gastrointestinal cancers: a cross-sectional study. World Journal of Surgical Oncology. 23(1). 45–45.
2.
Michels, Judith, Divya Venkatesh, Cailian Liu, et al.. (2023). APR-246 increases tumor antigenicity independent of p53. Life Science Alliance. 7(1). e202301999–e202301999. 4 indexed citations
3.
Budhu, Sadna, Rachel Giese, Aditi Gupta, et al.. (2021). Targeting Phosphatidylserine Enhances the Anti-tumor Response to Tumor-Directed Radiation Therapy in a Preclinical Model of Melanoma. Cell Reports. 34(2). 108620–108620. 31 indexed citations
4.
Hirschhorn, Daniel, Allison Betof Warner, Rachana Maniyar, et al.. (2021). Cyclophosphamide enhances the antitumor potency of GITR engagement by increasing oligoclonal cytotoxic T cell fitness. JCI Insight. 6(20). 5 indexed citations
5.
Campesato, Luís Felipe, Sadna Budhu, Jeremy H. Tchaicha, et al.. (2020). Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine. Nature Communications. 11(1). 4011–4011. 335 indexed citations breakdown →
6.
Mangarin, Levi, Cailian Liu, Roberta Zappasodi, et al.. (2020). 493 Tired and hungry: a potential role for CD47 in T cell exhaustion. SHILAP Revista de lepidopterología. A304.2–A305. 3 indexed citations
7.
Zappasodi, Roberta, Cynthia A. Sirard, Yanyun Li, et al.. (2019). Rational design of anti-GITR-based combination immunotherapy. Nature Medicine. 25(5). 759–766. 177 indexed citations
8.
Zappasodi, Roberta, Cynthia A. Sirard, Yanyun Li, et al.. (2019). Abstract 2711: Rational combination of GITR agonism with PD-1 blockade. Immunology. 2711–2711. 1 indexed citations
9.
Ricca, Jacob, Anton Oseledchyk, Tyler Walther, et al.. (2018). Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy. Molecular Therapy. 26(4). 1008–1019. 111 indexed citations
10.
Zappasodi, Roberta, Sadna Budhu, Matthew D. Hellmann, et al.. (2018). Non-conventional Inhibitory CD4+Foxp3−PD-1hi T Cells as a Biomarker of Immune Checkpoint Blockade Activity. Cancer Cell. 33(6). 1017–1032.e7. 113 indexed citations
11.
Budhu, Sadna, Nicholas F. Kuhn, Cailian Liu, et al.. (2016). Clonal Abundance of Tumor-Specific CD4 + T Cells Potentiates Efficacy and Alters Susceptibility to Exhaustion. Immunity. 44(1). 179–193. 39 indexed citations
12.
Nissan, Moriah H., Christine A. Pratilas, Alexis M. Jones, et al.. (2014). Loss of NF1 in Cutaneous Melanoma Is Associated with RAS Activation and MEK Dependence. Cancer Research. 74(8). 2340–2350. 219 indexed citations
13.
Snyder, Alexandra, Vladimir Makarov, Taha Merghoub, et al.. (2014). The neoantigen landscape underlying clinical response to ipilimumab.. Journal of Clinical Oncology. 32(15_suppl). 3003–3003. 10 indexed citations
14.
Schaer, David, Sadna Budhu, Cailian Liu, et al.. (2013). GITR Pathway Activation Abrogates Tumor Immune Suppression through Loss of Regulatory T-cell Lineage Stability. Cancer Immunology Research. 1(5). 320–331. 121 indexed citations
15.
Hirschhorn-Cymerman, Daniel, Sadna Budhu, Shigehisa Kitano, et al.. (2012). Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype. The Journal of Experimental Medicine. 209(11). 2113–2126. 115 indexed citations
16.
Cohen, Adam D., David Schaer, Cailian Liu, et al.. (2010). Agonist Anti-GITR Monoclonal Antibody Induces Melanoma Tumor Immunity in Mice by Altering Regulatory T Cell Stability and Intra-Tumor Accumulation. PLoS ONE. 5(5). e10436–e10436. 199 indexed citations
17.
Duan, Fei, Yun Lin, Cailian Liu, et al.. (2009). Immune Rejection of Mouse Tumors Expressing Mutated Self. Cancer Research. 69(8). 3545–3553. 12 indexed citations
18.
Engelhorn, Manuel E., José A. Guevara-Patiño, Taha Merghoub, et al.. (2008). Mechanisms of Immunization Against Cancer Using Chimeric Antigens. Molecular Therapy. 16(4). 773–781. 13 indexed citations
19.
Cohen, Adam D., Adi Diab, Miguel‐Angel Perales, et al.. (2006). Agonist Anti-GITR Antibody Enhances Vaccine-Induced CD8+ T-Cell Responses and Tumor Immunity. Cancer Research. 66(9). 4904–4912. 165 indexed citations
20.
Hamabata, Takashi, Cailian Liu, & Yoshifumi Takeda. (2002). Positive and negative regulation of water channel aquaporins in human small intestine by cholera toxin. Microbial Pathogenesis. 32(6). 273–277. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026